```html

Nervous System Lyme Disease

Overview

Lyme disease is a bacterial infection transmitted to humans through the bite of infected black‑legged (Ixodes) ticks. While many people think of Lyme disease as a skin‑rash or flu‑like illness, the bacteria Borrelia burgdorferi can spread to the central and peripheral nervous systems—a condition often called neuroborreliosis or “nervous system Lyme disease.”

Who it affects: Anyone bitten by an infected tick can develop neuroborreliosis, but certain groups are at higher risk:

• Residents and visitors of endemic areas (Northeast, Mid‑Atlantic, Upper Midwest of the United States, parts of Canada, Europe, and Asia).
• Children ages 5‑15 and adults aged 30‑60, who spend time outdoors in tick‑habitat.
• People who delay removal of a tick or who were not treated promptly for early Lyme disease.

Prevalence: According to the CDC, roughly 30,000 cases of Lyme disease are reported in the U.S. each year, but the true number may be 10‑12 times higher. Neuroborreliosis occurs in about 10‑15% of untreated early cases and up to 30% of those with disseminated disease.<sup>1</sup>

Symptoms

Neurologic involvement can appear weeks to months after the initial tick bite. Symptoms may be isolated or occur together, and they can mimic other neurological disorders, which makes early recognition crucial.

Early Neurologic Manifestations (Days–Weeks)

• Facial nerve palsy (Bell’s palsy): Sudden weakness or drooping of one or both sides of the face.
• Meningitis: Severe headache, neck stiffness, photophobia, and sometimes fever.
• Radiculopathy: Sharp, shooting pain radiating along a nerve root (e.g., shooting leg pain similar to sciatica).

Late Neurologic Manifestations (Months–Years)

• Encephalopathy: Cognitive fog, memory problems, difficulty concentrating, and mood changes.
• Peripheral neuropathy: Tingling, burning, or numbness in hands or feet.
• Ataxia: Unsteady gait or clumsiness.
• Chronic fatigue: Persistent, debilitating tiredness not relieved by rest.
• Sleep disturbances: Insomnia or non‑restorative sleep.
• Auditory & vestibular symptoms: Tinnitus, dizziness, or vertigo.

Other Possible Signs

• Joint pain or swelling (often concurrent with neurologic signs).
• Heart rhythm abnormalities (Lyme carditis) – not a neurologic sign but may coexist.
• Skin rash (erythema migrans) may have resolved before neurologic symptoms appear.

Causes and Risk Factors

Cause

Neuroborreliosis is caused by the spirochete Borrelia burgdorferi, which enters the bloodstream after a tick bite and can cross the blood‑brain barrier, inflaming the meninges, cranial nerves, and peripheral nerves.

Risk Factors

• Geographic exposure: Living in/visiting high‑incidence regions during spring‑summer when nymphal ticks are active.
• Outdoor activities: Hiking, camping, gardening, hunting, or any activity in wooded or grassy areas.
• Delayed tick removal: Ticks attached >36 hours dramatically increase transmission risk.
• Previous untreated early Lyme disease: Increases likelihood of dissemination.
• Immunocompromised status: HIV, cancer chemotherapy, or chronic steroids may impair clearance.

Diagnosis

Diagnosing nervous system Lyme disease is a blend of clinical assessment, exposure history, and laboratory testing. No single test is definitive; physicians often use a two‑tiered serologic approach combined with cerebrospinal fluid (CSF) analysis when neurologic disease is suspected.

1. Clinical Evaluation

• Document tick exposure, rash history, and timing of symptom onset.
• Neurologic exam to identify facial palsy, meningitis signs, sensory deficits, gait disturbances, etc.

2. Two‑Tier Serologic Testing

1. Enzyme‑linked immunosorbent assay (ELISA): Screens for IgM and IgG antibodies. Positive or equivocal results proceed to the second tier.
2. Western blot: Confirms antibodies against specific B. burgdorferi proteins (≥2 IgM bands or ≥5 IgG bands are considered positive).<sup>2</sup>

3. Cerebrospinal Fluid (CSF) Analysis

• Performed via lumbar puncture when meningitis or encephalopathy is suspected.
• Typical findings: Elevated white‑blood‑cell count (lymphocytic pleocytosis), increased protein, and presence of intrathecal anti‑B. burgdorferi antibodies (often expressed as a CSF/serum antibody index >1.5).

4. Imaging

• MRI of brain/spine: May show meningeal enhancement, cranial nerve inflammation, or white‑matter changes, but can be normal in many cases.
• CT scan: Usually performed only to rule out other acute intracranial pathology.

5. Other Tests

• Electrodiagnostic studies (EMG/NCS) for peripheral neuropathy.
• Neurocognitive testing if “brain fog” is prominent.

Because serology can remain positive for years, clinicians interpret results in the context of new neurologic signs and documented exposure.

Treatment Options

Prompt antibiotic therapy alleviates most neurologic symptoms and prevents long‑term sequelae. Treatment choice depends on disease severity, route of administration, and patient tolerance.

Antibiotic Regimens

Condition	Preferred Antibiotic(s)	Typical Duration
Early neurologic disease (facial palsy, meningitis, radiculopathy)	Doxycycline 100 mg PO BID* or Ceftriaxone 2 g IV daily	14–21 days
Late neurologic disease (encephalopathy, peripheral neuropathy)	Ceftriaxone 2 g IV daily (or Penicillin G 18–24 million U IV daily)	28 days
Pregnant or <5 y children	Intravenous Ceftriaxone or Oral Amoxicillin 500 mg TID	21–28 days

*Doxycycline is contraindicated in pregnant women and children <5 y due to tooth discoloration.

Adjunctive Therapies

• Steroids: Not routinely recommended but may be used for severe facial nerve swelling after antibiotics have begun.
• Pain management: NSAIDs, gabapentin, or duloxetine for neuropathic pain.
• Physical therapy: Improves muscle strength and gait stability after facial palsy or ataxia.

Lifestyle & Supportive Measures

• Maintain adequate hydration and balanced nutrition to aid immune recovery.
• Gradual return to activity; avoid overexertion during acute phases.
• Consider counseling or support groups for coping with chronic fatigue and cognitive symptoms.

Living with Nervous System Lyme Disease

Daily Management Tips

• Medication adherence: Finish the entire antibiotic course, even if symptoms improve early.
• Symptom diary: Record headaches, fatigue levels, and cognitive changes to discuss with your clinician.
• Sleep hygiene: Consistent bedtime, dark room, and limited screen time improve restorative sleep.
• Exercise: Low‑impact activities (walking, swimming, yoga) boost circulation without worsening fatigue.
• Brain training: Puzzles, memory apps, or structured learning can help counteract “brain fog.”
• Nutrition: Anti‑inflammatory foods (omega‑3 rich fish, berries, leafy greens) may mitigate neuroinflammation.
• Stress reduction: Mindfulness meditation, deep‑breathing, or tai chi lower cortisol, which can worsen neurologic symptoms.

When to Follow Up

Schedule a follow‑up visit 2–4 weeks after completing antibiotics to assess residual symptoms. Persistent neurologic deficits may require referral to a neurologist, neuro‑ophthalmologist (for facial palsy), or pain specialist.

Prevention

• Tick avoidance: Stay on cleared paths, avoid tall grass, and use insect repellents containing 30–40% DEET or picaridin.
• Protective clothing: Wear long sleeves, long pants, and tuck pants into socks.
• Tick checks: Perform thorough skin exams within 24 hours of outdoor exposure; remove attached ticks promptly with fine‑tipped tweezers.
• Landscaping: Keep lawns mowed, remove leaf litter, and create a 3‑foot barrier of wood chips between wooded areas and play spaces.
• Pet care: Use veterinarian‑recommended tick preventatives; check pets daily.
• Prophylactic antibiotics: A single dose of doxycycline (200 mg) within 72 hours of a known tick bite can be considered in high‑risk areas (per CDC guidelines).<sup>3</sup>

Complications

If left untreated or inadequately treated, neuroborreliosis can lead to serious, sometimes irreversible complications:

• Chronic neuropathic pain: Persistent burning or stabbing sensations.
• Persistent facial paralysis: May require surgical decompression or facial reanimation.
• Cognitive impairment: Long‑term memory loss, attention deficits, and mood disorders.
• Seizures: Rare but reported in advanced encephalitis.
• Cardiac involvement: Conduction block (AV block) can coexist, increasing sudden‑death risk.
• Post‑treatment Lyme disease syndrome (PTLDS): Ongoing fatigue, pain, and neurocognitive complaints despite appropriate therapy (estimated 10‑20% of treated patients).<sup>4</sup>

When to Seek Emergency Care

---

**References**

1. Centers for Disease Control and Prevention. “Lyme Disease Data and Statistics.” CDC.gov. Accessed July 2026.
2. Stanford Health Care. “Two‑Tier Testing for Lyme Disease.” Stanford Medicine. 2023.
3. CDC. “Post‑Exposure Prophylaxis for Lyme Disease.” CDC.gov. Updated 2024.
4. Halperin, J.J. et al. “Post‑Treatment Lyme Disease Syndrome: Clinical Review.” *Mayo Clinic Proceedings*, vol 97, no 2, 2022, pp 307‑319.
5. American Academy of Neurology. “Guidelines for the Management of Neuroborreliosis.” *Neurology*, 2021.

```